These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33573312)

  • 1. Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.
    Zaami S; Orrico A; Signore F; Cavaliere AF; Mazzi M; Marinelli E
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33573312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
    Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.
    Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
    BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.
    Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
    AJOB Empir Bioeth; 2018; 9(2):99-111. PubMed ID: 29847254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
    Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
    Zhytnik L; Peters M; Tilk K; Simm K; Tõnisson N; Reimand T; Maasalu K; Acharya G; Krjutškov K; Salumets A
    Hum Reprod Update; 2021 Oct; 27(6):1056-1085. PubMed ID: 34329448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.
    Minear MA; Alessi S; Allyse M; Michie M; Chandrasekharan S
    Annu Rev Genomics Hum Genet; 2015; 16():369-98. PubMed ID: 26322648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening: current practice, new developments, ethical challenges.
    de Jong A; Maya I; van Lith JM
    Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing.
    Haidar H; Le Clerc-Blain J; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
    BMC Pregnancy Childbirth; 2021 Jan; 21(1):54. PubMed ID: 33441113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emergence and Global Spread of Noninvasive Prenatal Testing.
    Ravitsky V; Roy MC; Haidar H; Henneman L; Marshall J; Newson AJ; Ngan OMY; Nov-Klaiman T
    Annu Rev Genomics Hum Genet; 2021 Aug; 22():309-338. PubMed ID: 33848430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prenatal testing: ethics and policy considerations.
    Vanstone M; King C; de Vrijer B; Nisker J
    J Obstet Gynaecol Can; 2014 Jun; 36(6):515-526. PubMed ID: 24927192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues associated with prenatal screening using non-invasive prenatal testing for sex chromosome aneuploidy.
    Johnston M; Warton C; Pertile MD; Taylor-Sands M; Delatycki MB; Hui L; Savulescu J; Mills C
    Prenat Diagn; 2023 Feb; 43(2):226-234. PubMed ID: 35929376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.
    Griffin B; Edwards S; Chitty LS; Lewis C
    J Psychosom Obstet Gynaecol; 2018 Mar; 39(1):11-18. PubMed ID: 28635528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens' attitudes.
    Kater-Kuipers A; Bakkeren IM; Riedijk SR; Go ATJI; Polak MG; Galjaard RH; de Beaufort ID; Bunnik EM
    Eur J Hum Genet; 2021 Jan; 29(1):2-10. PubMed ID: 32759960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perceptions on the Advancement of Noninvasive Prenatal Testing for Sickle Cell Disease among Black Women in the United States.
    Thomas SP; Fletcher FE; Willard R; Ranson TM; Bonham VL
    AJOB Empir Bioeth; 2024; 15(2):154-163. PubMed ID: 38349128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals.
    Claesen-Bengtson Z; Bowman-Smart H; Vermeersch E; Vermeesch JR; Henneman L; Borry P
    Eur J Hum Genet; 2024 Mar; 32(3):309-316. PubMed ID: 38278868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions.
    Vanstone M; Cernat A; Nisker J; Schwartz L
    BMC Med Ethics; 2018 Apr; 19(1):27. PubMed ID: 29661182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.